home / stock / apre / apre short
Short Information | Aprea Therapeutics Inc. (NYSE:APRE)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 20,507 |
Total Actual Volume | 1,405,595 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 1,025 |
Average Short Percentage | 1.65% |
Is there a APRE Short Squeeze or Breakout about to happen?
See the APRE Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
02-12-2020 | $34.88 | $34.52 | $36.00 | $34.11 | 25,629 | 378 | 1.47% |
02-11-2020 | $34.96 | $34.62 | $36.895 | $34.41 | 41,841 | 626 | 1.5% |
02-10-2020 | $35.35 | $34.80 | $36.25 | $34.06 | 46,652 | 642 | 1.38% |
02-07-2020 | $36.31 | $35.11 | $37.42 | $34.04 | 61,776 | 244 | 0.39% |
02-06-2020 | $38.15 | $36.02 | $38.37 | $35.01 | 56,377 | 1,228 | 2.18% |
02-05-2020 | $39.37 | $37.96 | $39.37 | $37.185 | 42,989 | 749 | 1.74% |
02-04-2020 | $39.63 | $38.48 | $39.7855 | $37.12 | 67,950 | 185 | 0.27% |
02-03-2020 | $39.27 | $39.50 | $39.93 | $37.48 | 73,734 | 878 | 1.19% |
01-31-2020 | $37.42 | $38.34 | $38.73 | $36.60 | 65,042 | 1,864 | 2.87% |
01-30-2020 | $38.97 | $37.23 | $38.97 | $36.2884 | 73,125 | 3,804 | 5.2% |
01-29-2020 | $35.76 | $35.85 | $36.8148 | $34.00 | 90,899 | 1,259 | 1.39% |
01-28-2020 | $38.12 | $35.94 | $38.97 | $35.31 | 122,631 | 1,134 | 0.92% |
01-27-2020 | $37.95 | $37.84 | $38.78 | $36.18 | 102,327 | 733 | 0.72% |
01-24-2020 | $40.51 | $38.58 | $40.74 | $38.40 | 83,992 | 666 | 0.79% |
01-23-2020 | $39.87 | $40.34 | $40.6645 | $38.48 | 62,502 | 1 | 0% |
01-22-2020 | $39.68 | $40.00 | $40.25 | $38.45 | 118,744 | 339 | 0.29% |
01-21-2020 | $39.45 | $38.83 | $39.94 | $38.49 | 68,442 | 402 | 0.59% |
01-17-2020 | $42.18 | $39.48 | $42.7725 | $39.03 | 61,387 | 1,762 | 2.87% |
01-16-2020 | $40.53 | $42.46 | $43.24 | $38.365 | 106,992 | 1,778 | 1.66% |
01-15-2020 | $40.37 | $40.30 | $40.99 | $39.70 | 32,564 | 1,835 | 5.64% |
News, Short Squeeze, Breakout and More Instantly...
Aprea Therapeutics Inc. Company Name:
APRE Stock Symbol:
NYSE Market:
Pre-clinical findings underscore the potential of APR-1051, a next-generation WEE1 kinase inhibitor, to be a well-tolerated and effective treatmen...
Pre-clinical findings underscore the potential of APR-1051, a next-generation WEE1 kinase inhibitor, to be a well-tolerated and effective treatment for Cyclin E-overexpressing cancers IND for APR-1051 has been cleared; details on planned Phase 1 first in human trial (ACESOT-1051) pr...
First-in-class macrocyclic ATR inhibitor, ATRN-119, on track to complete dose escalation and potentially generate human efficacy data in H2 2024 U.S. FDA cleared IND for APR-1051, a highly selective and potentially best-in-class oral WEE1 inhibitor; Company plans to initiate Phase ...